about
Time to Amyloid Positivity and Preclinical Changes in Brain Metabolism, Atrophy, and Cognition: Evidence for Emerging Amyloid Pathology in Alzheimer's DiseaseIs verbal episodic memory in elderly with amyloid deposits preserved through altered neuronal function?Widespread disruption of functional brain organization in early-onset Alzheimer's diseaseMild cognitive impairment with suspected nonamyloid pathology (SNAP): Prediction of progressionTau, amyloid, and hypometabolism in a patient with posterior cortical atrophy.Cerebrospinal fluid biomarkers and cerebral atrophy in distinct clinical variants of probable Alzheimer's disease.Prevalence of cerebral amyloid pathology in persons without dementia: a meta-analysis.Prevalence of amyloid PET positivity in dementia syndromes: a meta-analysisCerebral perfusion and glucose metabolism in Alzheimer's disease and frontotemporal dementia: two sides of the same coin?The behavioural/dysexecutive variant of Alzheimer's disease: clinical, neuroimaging and pathological features.Atrophy patterns in early clinical stages across distinct phenotypes of Alzheimer's disease.PET Imaging of Tau Deposition in the Aging Human Brain.The effect of amyloid pathology and glucose metabolism on cortical volume loss over time in Alzheimer's diseaseTau PET patterns mirror clinical and neuroanatomical variability in Alzheimer's disease.Amyloid imaging in clinical trials.Arterial spin labeling-based Z-maps have high specificity and positive predictive value for neurodegenerative dementia compared to FDG-PETAmyloid imaging in prodromal Alzheimer's diseaseLong-term effects of amyloid, hypometabolism, and atrophy on neuropsychological functions.Metabolic networks underlying cognitive reserve in prodromal Alzheimer disease: a European Alzheimer disease consortium project.A neuroimaging approach to capture cognitive reserve: Application to Alzheimer's disease.Quantification of Tau Load Using [(18)F]AV1451 PET.The Association of Glucose Metabolism and Eigenvector Centrality in Alzheimer's Disease.Impact of molecular imaging on the diagnostic process in a memory clinic.Prediction of dementia in MCI patients based on core diagnostic markers for Alzheimer disease.Application of Machine Learning to Arterial Spin Labeling in Mild Cognitive Impairment and Alzheimer Disease.Clinicopathological correlations in behavioural variant frontotemporal dementia.[Early diagnosis of Alzheimer disease: the role of Positron Emission Tomography (PET)].Frontotemporal dementia with the V337M MAPT mutation: Tau-PET and pathology correlations.The Complexity of Subjective Cognitive Decline.Local and distant relationships between amyloid, tau and neurodegeneration in Alzheimer's Disease.Association of Cerebral Amyloid-β Aggregation With Cognitive Functioning in Persons Without Dementia.Differential effects of cognitive reserve and brain reserve on cognition in Alzheimer disease.Longitudinal amyloid imaging using 11C-PiB: methodologic considerations.Differential effect of APOE genotype on amyloid load and glucose metabolism in AD dementia.Amyloid and its association with default network integrity in Alzheimer's disease.Prediction of AD dementia by biomarkers following the NIA-AA and IWG diagnostic criteria in MCI patients from three European memory clinics.Amyloid burden and metabolic function in early-onset Alzheimer's disease: parietal lobe involvement.Resting metabolic connectivity in prodromal Alzheimer's disease. A European Alzheimer Disease Consortium (EADC) project.Evidence-based Interpretation of Amyloid-β PET Results: A Clinician's Tool.Longitudinal imaging of Alzheimer pathology using [11C]PIB, [18F]FDDNP and [18F]FDG PET.
P50
Q33695122-5CB59902-7815-4D59-9843-2115D115C11EQ33872248-A47292D7-1859-44F6-9BF9-AA6C71DA616BQ33981820-7338E77D-9F29-47ED-812E-A1BE845F4210Q35106472-2D89CF3F-1EE6-44D2-AF55-FCD1F4C896EAQ35241767-36B9BA95-50E9-4AD6-AF3D-5B22C965CA84Q35735066-F91F9280-157E-4873-8D1B-7689164A29CBQ35800785-FCD0270E-F90D-4AA7-84FB-EF45905B1815Q35896890-B1CE4D14-0AB5-4ED0-959D-F654815F478FQ36034391-523F8743-2F51-4E58-924A-7AAAF5C37B32Q36217479-131A607C-FE27-4A32-8807-B9A5945FBB9EQ36408912-4FDB11CB-C2FE-4ACD-9D4A-D90B92FDF8DBQ36654193-03C86DC6-3D26-475B-A3D9-21D7845F7580Q37029599-C1CE4B15-3A47-485F-A610-E70D1B8BD8B5Q37220632-51B54BE1-C9B8-4162-8264-C4720733F457Q38647907-7C541A19-B8F7-4951-BE8B-628E4273C2EDQ38857172-C6AECA79-ACAC-4476-A388-C5C9E418C4AFQ39182933-75F0A213-376F-4E45-A3E6-7080DD7230FFQ39206880-ADB3F5DC-9BBD-47D7-A5BD-89A217F9D9FDQ39301087-1A9B4169-1EAD-4D04-8F9F-92B80B80BF16Q40153300-6EE93AC3-0D49-4B91-9AF8-98BB4182D0D8Q40259674-FDB3C499-8A6F-473F-91A0-2A7576D7A9FDQ40491600-4507A9C5-FE08-4AE8-BD96-35463B7DD62DQ44266621-02613844-DBAE-4039-92AA-835C5ED155FAQ44619067-4A5FEC93-E7BA-4225-8ED0-C0957A5157F4Q45950771-99FE71A4-FAA7-4F50-A626-CEE3A28A69A9Q45952280-2F419CF0-7F42-45B7-86E5-D648F3C04C1FQ46173128-4AD47E51-3316-4561-89FB-FE5EB97E4C3EQ46677826-09F5438F-A43D-4F8C-970B-FC1BD2AFE8B2Q46680853-96815506-5E34-4031-BEFC-F8865D88738AQ46682283-15D1A57E-FEDC-466D-A227-E0A97BA9B05BQ46759895-18A59410-D7DC-4E2D-A648-7A1E2587816FQ47252483-C5FD3455-8480-4FFF-A834-47FCB5FBB6BDQ47791420-54654C1E-2E7D-4AB5-B606-9DB8EC19899FQ48246691-2C287498-67C5-478B-8BAD-FA894AA74EA3Q48254113-DF1670A8-B518-471D-96F4-EFE51A786ECEQ48346421-AC02E2AB-7EC0-458F-98F6-2D504A7F7F35Q48533050-1DE38F52-B96A-4D00-9336-7806DA4FF991Q48641428-539EA279-29B9-4FAC-AFEB-DD9B3B26F414Q50045654-98B8C560-1D7A-4216-BB49-A2DD3E504697Q50764182-86E7AC70-2972-42ED-A844-33FA20848BF8
P50
name
Rik Ossenkoppele
@en
type
label
Rik Ossenkoppele
@en
prefLabel
Rik Ossenkoppele
@en